University of New Mexico Interdisciplinary HPV Prevention Center

新墨西哥大学跨学科 HPV 预防中心

基本信息

项目摘要

Over 6 million new cases of sexually transmitted human papillomavirus (HPVs) infections are reported every year making HPV the most common sexually transmitted agent world-wide. At least 15 carcinogenic HPV types cause virtually all cervical cancers however; the costly HPV vaccine licensed in 2006 covers only HPV types 6/11/16/18 and has no therapeutic effect on established infections. Thus all women must continue routine cervical screening at a US cost of $4-5 billion annually. More importantly, the majority of women alive today are still at risk for developing cervical cancer. In addition, the current vaccine program presently leaves all men unprotected. Given these considerations and the fact that cervical cancer is a disease of disparities, it is unlikely that projected disease reductions will be realized with current strategies. Programs to characterize current US HPV vaccine implementation and effectiveness are needed and continuing efforts to better understand HPV biology and to develop broadly protective prevention strategies and therapeutics for existing infections remain critical. The specific aims of this application are: 1) To establish the University of New Mexico Interdisciplinary HPV Prevention Center that incorporates research approaches to address these gaps in knowledge. 2) To fund and support 4 projects representing a spectrum of interdisciplinary approaches including: A) modeling of PV-host interactions in 3 dimensions to define elements of epithelial cell biology and immunity that contribute to the pathogenesis and prevention of infections; B) utilizing novel vaccine strategies based on virus-display technology to generate broad protection against a majority of HPV infections; C) utilizing a unique bioinformatics system that captures all events of a US population-based cervical screening program to characterize implementation and effectiveness of primary and secondary HPV interventions; and D) developing a set of web-based tools to promote the informed adoption of HPV and other STI prevention. 3) To establish 2 cores housing shared resources to support these interdisciplinary research approaches: A) a biostatistics and bioinformatics core and B) a virus infection core supporting technologies for virus production, quantitation, and animal imaging and housing a biospecimen resource.
每年有超过600万例新的性传播人乳头瘤病毒(HPV)感染病例报告,使HPV成为世界范围内最常见的性传播媒介。然而,至少有15种致癌的HPV类型导致几乎所有的宫颈癌; 2006年批准的昂贵的HPV疫苗仅涵盖HPV 6/11/16/18型,对已建立的感染没有治疗效果。因此,所有妇女都必须继续进行常规宫颈筛查,美国每年的费用为40亿至50亿美元。更重要的是,今天活着的大多数妇女仍然有患宫颈癌的风险。此外,目前的疫苗计划使所有男子都得不到保护。考虑到这些因素以及宫颈癌是一种差异性疾病的事实,目前的战略不太可能实现预计的疾病减少。目前美国HPV疫苗的实施和有效性的特点的计划是必要的,继续努力,以更好地了解HPV生物学和开发广泛的保护性预防策略和治疗现有的感染仍然至关重要。本申请的具体目的是:1)建立新墨西哥州大学跨学科HPV预防中心,该中心采用研究方法来解决这些知识差距。2)资助和支持代表一系列跨学科方法的4个项目,包括:A)在3个维度上建模PV与宿主相互作用,以定义有助于感染发病机制和预防的上皮细胞生物学和免疫学要素; B)利用基于病毒展示技术的新型疫苗策略,对大多数HPV感染产生广泛保护; C)利用独特的生物信息学系统,捕获美国基于人群的宫颈筛查计划的所有事件,以表征初级和二级HPV干预措施的实施和有效性;以及D)开发一套基于网络的工具,以促进HPV和其他STI预防的知情采用。3)建立2个核心,容纳共享资源,以支持这些跨学科研究方法:A)生物统计学和生物信息学核心和B)病毒感染核心,支持病毒生产、定量和动物成像技术,并容纳生物标本资源。

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Human papilloma virions in the laboratory.
  • DOI:
    10.1016/j.jcv.2014.06.014
  • 发表时间:
    2014-10
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Dunne, Eileen F.;Markowitz, Lauri E.;Taylor, La'shan D.;Unger, Elizabeth R.;Wheeler, Cosette M.
  • 通讯作者:
    Wheeler, Cosette M.
Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses.
  • DOI:
    10.1016/j.vaccine.2011.04.051
  • 发表时间:
    2011-06-20
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Hunter, Zoe;Tumban, Ebenezer;Dziduszko, Agnieszka;Chackerian, Bryce
  • 通讯作者:
    Chackerian, Bryce
Three-year risk of cervical precancer and cancer after the detection of low-risk human papillomavirus genotypes targeted by a commercial test.
商业测试检测到低风险人乳头瘤病毒基因型后,宫颈癌前病变和癌症的三年风险。
  • DOI:
    10.1097/aog.0000000000000013
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    7.2
  • 作者:
    Castle,PhilipE;Hunt,WilliamC;Langsfeld,Erika;Wheeler,CosetteM;NewMexicoHPVPapRegistrySteeringCommittee
  • 通讯作者:
    NewMexicoHPVPapRegistrySteeringCommittee
The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.
  • DOI:
    10.1002/ijc.28605
  • 发表时间:
    2014-08-01
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Wheeler, Cosette M.;Hunt, William C.;Cuzick, Jack;Langsfeld, Erika;Robertson, Michael;Castle, Philip E.
  • 通讯作者:
    Castle, Philip E.
No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study.
在一项基于大规模人群的研究中,没有证据表明人乳头瘤病毒基因型之间对高级鳞状上皮内病变风险有协同作用。
  • DOI:
    10.1093/infdis/jit577
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Wentzensen,Nicolas;Nason,Martha;Schiffman,Mark;Dodd,Lori;Hunt,WilliamC;Wheeler,CosetteM;NewMexicoHPVPapRegistrySteeringCommittee
  • 通讯作者:
    NewMexicoHPVPapRegistrySteeringCommittee
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cosette Marie Wheeler其他文献

Cosette Marie Wheeler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cosette Marie Wheeler', 18)}}的其他基金

Epidemiology and Prevention Interdisciplinary Center for Sexually Transmitted Inf
性传播感染疾病流行病学与预防跨学科中心
  • 批准号:
    8769910
  • 财政年份:
    2014
  • 资助金额:
    $ 259.8万
  • 项目类别:
LEADERSHIP/ADMIN CORE
领导/管理核心
  • 批准号:
    8566783
  • 财政年份:
    2012
  • 资助金额:
    $ 259.8万
  • 项目类别:
New Mexico HPV Outcomes, Practice Effectiveness and Surveillance (NM-HOPES)
新墨西哥州 HPV 结果、实践有效性和监测 (NM-HOPES)
  • 批准号:
    9415520
  • 财政年份:
    2011
  • 资助金额:
    $ 259.8万
  • 项目类别:
New Mexico HPV Outcomes, Practice Effectiveness and Surveillance (NM-HOPES)
新墨西哥州 HPV 结果、实践有效性和监测 (NM-HOPES)
  • 批准号:
    8531007
  • 财政年份:
    2011
  • 资助金额:
    $ 259.8万
  • 项目类别:
New Mexico HPV Outcomes, Practice Effectiveness and Surveillance (NM-HOPES)
新墨西哥州 HPV 结果、实践有效性和监测 (NM-HOPES)
  • 批准号:
    8729294
  • 财政年份:
    2011
  • 资助金额:
    $ 259.8万
  • 项目类别:
New Mexico HPV Outcomes, Practice Effectiveness and Surveillance (NM-HOPES)
新墨西哥州 HPV 结果、实践有效性和监测 (NM-HOPES)
  • 批准号:
    8230057
  • 财政年份:
    2011
  • 资助金额:
    $ 259.8万
  • 项目类别:
New Mexico HPV Outcomes, Practice Effectiveness and Surveillance (NM-HOPES)
新墨西哥州 HPV 结果、实践有效性和监测 (NM-HOPES)
  • 批准号:
    8884548
  • 财政年份:
    2011
  • 资助金额:
    $ 259.8万
  • 项目类别:
Comparative Effectiveness of the Cervical Cancer Screening Process: Past, Present
宫颈癌筛查过程的有效性比较:过去、现在
  • 批准号:
    8555414
  • 财政年份:
    2011
  • 资助金额:
    $ 259.8万
  • 项目类别:
New Mexico HPV Outcomes, Practice Effectiveness and Surveillance (NM-HOPES)
新墨西哥州 HPV 结果、实践有效性和监测 (NM-HOPES)
  • 批准号:
    8337732
  • 财政年份:
    2011
  • 资助金额:
    $ 259.8万
  • 项目类别:
University of New Mexico Interdisciplinary HPV Prevention Center
新墨西哥大学跨学科 HPV 预防中心
  • 批准号:
    7929531
  • 财政年份:
    2009
  • 资助金额:
    $ 259.8万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 259.8万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 259.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 259.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 259.8万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 259.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 259.8万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 259.8万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 259.8万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 259.8万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 259.8万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了